Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
1.15B
Market cap1.15B
Price-Earnings ratio
17.77
Price-Earnings ratio17.77
Dividend yield
Dividend yield
Average volume
284.85K
Average volume284.85K
High today
$36.28
High today$36.28
Low today
$34.40
Low today$34.40
Open price
$35.71
Open price$35.71
Volume
268.50K
Volume268.50K
52 Week high
$50.79
52 Week high$50.79
52 Week low
$29.19
52 Week low$29.19

Stock Snapshot

The current Collegium Pharmaceutical(COLL) stock price is $35.39, with a market capitalization of 1.15B. The stock trades at a price-to-earnings (P/E) ratio of 17.77.

During the trading session on 2026-08-01, Collegium Pharmaceutical(COLL) shares reached a daily high of $36.28 and a low of $34.40. At a current price of $35.39, the stock is +2.9% higher than the low and still -2.5% under the high.

Trading activity shows a volume of 268.5K, compared to an average daily volume of 284.85K.

The stock's 52-week range extends from a low of $29.19 to a high of $50.79.

The stock's 52-week range extends from a low of $29.19 to a high of $50.79.

COLL News

Simply Wall St 3d
How Collegium's Quarterly Beat but Softer Outlook Could Reframe Collegium Pharmaceutical Investors - simplywall.st

...

How Collegium's Quarterly Beat but Softer Outlook Could Reframe Collegium Pharmaceutical Investors - simplywall.st

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.